Are there any differences between features of proteins expressed in malignant and benign breast cancers?

Journal of Research in Medical Sciences

Volumn 15, Issue 6, 2010, Pages 299-309

  Ebrahimi, Mansour ^a   Ebrahimie, Esmaeil ^b   Shamabadi, Narges ^c   Ebrahimi, Mahdi ^d  

^a UNIVERSITY OF QOM   (Iran)

^b SHIRAZ UNIVERSITY   (Iran)

^c ISLAMIC AZAD UNIVERSITY   (Iran)

^d SAARLAND UNIVERSITY   (Germany)

Author keywords

Benign; Bioinformatics; Breast cancer; Malignant; Modeling

Indexed keywords

ISOLEUCINE; METHIONINE;

ALGORITHM; AMINO TERMINAL SEQUENCE; ARTICLE; BIOINFORMATICS; BREAST CANCER; BREAST DISEASE; CLUSTER ANALYSIS; CONTROLLED STUDY; DECISION TREE; PREDICTION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SCREENING TEST;

EID: 78449309608     PISSN: 17351995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Higa GM. Breast cancer: beyond the cutting edge. Expert Opin Pharmacother 2009;10(15):2479-98.
2. Barr L, Evans DG. There may never be a final cure for breast cancer. Eur J Surg Oncol 2001;27(4):338-9.
3. Pavelic K, Gall-Troselj K. Recent advances in molecular genetics of breast cancer. J Mol Med 2001;79(10):566-73.
4. Drukier AK, Ossetrova N, Schors E, Krasik G, Grigoriev I, Koenig C, et al. High-sensitivity blood-based detection of breast cancer by multi photon detection diagnostic proteomics. J Proteome Res 2006;5(8):1906-15.
5. Shen R, Olshen AB, Ladanyi M. Integrative clustering of multiple genomic data types using a joint latent variable model with application to breast and lung cancer subtype analysis. Bioinformatics 2009;25(22):2906-12.
6. Wiwanitkit V. Mutation-prone positions within the estrogen receptor. Taiwan J Obstet Gynecol 2009;48(2):130-2.
7. Laubenbacher R, Hower V, Jarrah A, Torti SV, Shulaev V, Mendes P, et al. A systems biology view of cancer. Biochim Biophys Acta 2009;1796(2):129-39.
8. Zhang X, Lu X, Shi Q, Xu XQ, Leung HC, Harris LN, et al. Recursive SVM feature selection and sample classification for mass-spectrometry and microarray data. BMC Bioinformatics 2006;7:197.
9. Liu HX, Zhang RS, Luan F, Yao XJ, Liu MC, Hu ZD, et al. Diagnosing breast cancer based on support vector machines. J Chem Inf Comput Sci 2003;43(3):900-7.
10. Henneges C, Bullinger D, Fux R, Friese N, Seeger H, Neubauer H, et al. Prediction of breast cancer by profiling of urinary RNA metabolites using Support Vector Machine-based feature selection. BMC Cancer 2009;9:104.
11. Hwang T, Sicotte H, Tian Z, Wu B, Kocher JP, Wigle DA, et al. Robust and efficient identification of biomarkers by classifying features on graphs. Bioinformatics 2008;24(18):2023-9.
12. Tyson DR, Ornstein DK. Proteomics of cancer of hormone-dependent tissues. Adv Exp Med Biol 2008;630:133-47.
13. Zhang D, Tai LK, Wong LL, Chiu LL, Sethi SK, Koay ES. Proteomic study reveals that proteins involved in metabolic and detoxification pathways are highly expressed in HER-2/neu-positive breast cancer. Mol Cell Proteomics 2005;4(11):1686-96.
14. Tan KC, Yu Q, Heng CM, Lee TH. Evolutionary computing for knowledge discovery in medical diagnosis. Artif Intell Med 2003;27:129-54.
15. Nikolsky Y, Ekins S, Nikolskaya T, Bugrim A. A novel method for generation of signature networks as biomarkers from complex high throughput data. Toxicol Lett 2005;158(1):20-9.
16. Yuan Q, Cai C, Xiao H, Liu X, Wen Y. SVM-aided cancer diagnosis based on the concentration of the macroelement and microelement in human blood. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 2007;24(3):513-518.
17. Luk JM, Lam BY, Lee NP, Ho DW, Sham PC, Chen L, et al. Artificial neural networks and decision tree model analysis of liver cancer proteomes. Biochem Biophys Res Commun 2007;361(1):68-73.
18. Rew DA. Modelling in surgical oncology--part III: massive data sets and complex systems. Eur J Surg Oncol 2000;26(8):805-9.
19. Ye X, Fu Z, Wang H, Du W, Wang R, Sun Y, et al. A computerized system for signal detection in spontaneous reporting system of Shanghai China. Pharmacoepidemiol Drug Saf 2009;18(2):154-8.
20. Gromiha MM, Yabuki Y. Functional discrimination of membrane proteins using machine learning techniques. BMC Bioinformatics 2008;9:135.
21. Thai KM, Ecker GF. Similarity-based SIBAR descriptors for classification of chemically diverse hERG blockers. Mol Divers 2009;13(3):321-36.
22. Dancey D, Bandar ZA, McLean D. Logistic model tree extraction from artificial neural networks. IEEE Trans Syst Man Cybern B Cybern 2007;37(4):794-802.
23. Gromiha MM. Prediction of protein stability upon point mutations. Biochem Soc Trans 2007;35(Pt 6):1569-73.
24. Laronga C, Drake RR. Proteomic approach to breast cancer. Cancer Control 2007;14(4):360-8.
25. Li J, Zhang Z, Rosenzweig J, Wang YY, Chan DW. Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clin Chem 2002;48(8):1296-304.
26. Ryu DD, Nam DH. Recent progress in biomolecular engineering. Biotechnol Prog 2000;16(1):2-16.
27. Sarvaiya HA, Yoon JH, Lazar IM. Proteome profile of the MCF7 cancer cell line: a mass spectrometric evaluation. Rapid Commun Mass Spectrom 2006;20(20):3039-55.
28. Blokh D, Stambler I, Afrimzon E, Platkov M, Shafran Y, Korech E, et al. Comparative analysis of cell parameter groups for breast cancer detection. Comput Methods Programs Biomed 2009;94(3):239-49.
29. Ebrahimi M, Ebrahimie E, Ebrahimi M. Searching for patterns of thermostability in proteins and defining the main features contributing to enzyme thermostability through screening, clustering, and decision tree algorithms. EXCLI J 2009;8:218-33.
30. Qu X, Swanson R, Day R, Tsai J. A guide to template based structure prediction. Curr Protein Pept Sci 2009;10(3):270-85.
31. Hoja-Lukowicz D, Przybylo M, Pochec E, Drabik A, Silberring J, Kremser M, et al. The new face of nucleolin in human melanoma. Cancer Immunol Immunother 2009;58(9):1471-80.
32. Liang X, Zhao J, Hajivandi M, Wu R, Tao J, Amshey JW, et al. Quantification of membrane and membrane-bound proteins in normal and malignant breast cancer cells isolated from the same patient with primary breast carcinoma. J Proteome Res 2006;5(10):2632-41.
33. Smith-Beckerman DM, Fung KW, Williams KE, Auersperg N, Godwin AK, et al. Proteome changes in ovarian epithelial cells derived from women with BRCA1 mutations and family histories of cancer. Mol Cell Proteomics 2005;4(2):156-68.
34. Dixit A, Yi L, Gowthaman R, Torkamani A, Schork NJ, Verkhivker GM. Sequence and structure signatures of cancer mutation hotspots in protein kinases. PLoS One 2009;4(10):e7485.
35. Xie H, Wang M, Bonaldo Mde F, Smith C, Rajaram V, Goldman S, et al. High-throughput sequence-based epigenomic analysis of Alu repeats in human cerebellum. Nucleic Acids Res 2009;37(13):4331-40.
36. Ryan MC, Zeeberg BR, Caplen NJ, Cleland JA, Kahn AB, Liu H, et al. SpliceCenter: a suite of web-based bioinformatics applications for evaluating the impact of alternative splicing on RT-PCR, RNAi, microarray, and peptidebased studies. BMC Bioinformatics 2008;9:313.
37. Raphael BJ, Volik S, Yu P, Wu C, Huang G, Linardopoulou EV, et al. A sequence-based survey of the complex structural organization of tumor genomes. Genome Biol 2008;9(3):R59.
38. Misek DE, Imafuku Y, Hanash SM. Application of proteomic technologies to tumor analysis. Pharmacogenomics 2004;5(8):1129-37.